PRTG Portage Biotech
- 0.271
- +0.011+4.27%
- 0.263
- -0.008-3.10%
Portage Biotech News
Portage Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Portage Biotech | D: Filing D
Portage Biotech | D: Filing D
Portage Biotech | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Portage Biotech | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Portage Biotech | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)
Portage Biotech | 4: Statement of changes in beneficial ownership of securities
Portage Biotech | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)
Portage Biotech | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Portage Biotech | 4: Statement of changes in beneficial ownership of securities
Portage Biotech | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Portage Biotech | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Portage Biotech | 4: Statement of changes in beneficial ownership of securities
Portage Biotech | 4: Statement of changes in beneficial ownership of securities
Portage Biotech | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Portage Biotech | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Portage Biotech | 3: Initial statement of beneficial ownership of securities
Analysis
Price Target
No Data
